Given that REDD1 expression is also upregulated in acute kidney injury (AKI) [56, 57], interventions targeting REDD1 in the context of nephropathies including AKI and DN could improve current treatment paradigms. This evidence concerns the gene DDIT4 and liver dysplastic nodule.